SK

Satyendra Kumar Shambhu Prasad Pandey

Active Director Director DIN 11111449
DIN 11111449 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Satyendra Kumar Shambhu Prasad Pandey

Data last updated:

Satyendra Kumar Shambhu Prasad Pandey is a Director at Sumathico Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11111449
Primary Designation Director
Industry Pharma
First Appointment 29 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 May 20252025Active

Board colleagues of Satyendra Kumar Shambhu Prasad Pandey

Directorship timeline

Open interactive timeline →
Sumathico Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Satyendra Kumar Shambhu Prasad Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satyendra Kumar Shambhu Prasad Pandey

Satyendra Kumar Shambhu Prasad Pandey currently holds 1 directorship: Sumathico Pharmaceuticals Private Limited (Director, since 29 May 2025).

Satyendra Kumar Shambhu Prasad Pandey was first appointed on 29 May 2025 as Director at Sumathico Pharmaceuticals Private Limited.

The current boards of Satyendra Kumar Shambhu Prasad Pandey's companies include Vibha Satyendrakumar Pandey (Sumathico Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available